The injectable route of administration is
quite common for faster delivery of drugs and medication. It is used
for various purposes such as diagnosis, prevention, and treatment of
diseases. These purposes require safe injectable route of administration
to patients. Injectable route of administration should also be safe for
healthcare providers to deliver. Safe injection is the method which
should be risk free, harmless to patient and provider and should not
cause any infection. Safety syringes protect health care providers from
needlestick injuries. These are equipped with an inbuilt safety
mechanism and needles that are detachable or permanently attached.
Various countries have introduced legislation for compulsory usage of
safety syringes from prevention of needle stick injuries. This
initiative has led to more common use for safety syringes.
Rise in prevalence of chronic diseases
such as diabetes and increase in incidence of needlestick injuries are
the major factors boosting the growth of the global safety syringes
market. According to the WHO, 3 million accidental needle-stick injuries
were reported in 2003, with 37% new hepatitis B cases in health care
workers, 39% of new hepatitis C cases, and around 5.5% of new HIV cases.
Moreover, around 422 million people had diabetes across the world in
2016. Increase in health care spending, rise in prevalence of blood
borne diseases, and surge in awareness about the benefits of safety
syringes drive the global safety syringes market. Preference for other
delivery methods in developing countries and lack of awareness about
needlestick injuries are the factors restraining the global safety
syringes market.
The global safety syringes market can be
segmented based on product type, therapy, end-user, and region. In terms
of product type, the global market can be bifurcated into retractable
safety syringes and non-retractable safety syringes. The retractable
safety syringes segment dominated the global market in 2017 due to ease
of use, reduced time, and improved safety. The retractable safety
syringes segment can be classified into manual retractable syringes and
automatic retractable syringes. The manual retractable safety syringes
sub-segment held major share of the retractable safety syringes segment
in 2017. The sub-segment is anticipated to continue to dominate the
segment during the forecast period owing to lower cost than automatic
retractable syringes. Based on therapy, the global safety syringes
market can be categorized into insulin, glucagon-like peptide-1 (GLP-1),
tuberculosis, growth hormones, and others. Insulin and tuberculosis are
lucrative segments due to high incidence of diabetes and tuberculosis.
In terms of end-user, the global market can be divided into hospitals,
clinics, ambulatory surgical centers, and others. The hospitals segment
dominated the global market in 2017 owing to developed infrastructure
and technologically advanced therapeutic procedures.
In terms of region, the global safety
syringes market can be segmented into North America, Europe, Asia
Pacific, Latin America, and Middle East & Africa. North America
dominated the global market in 2017 and the trend is expected to
continue during the forecast period. Well-established health care
infrastructure, high number of needlestick injuries, and rise in
awareness about prevention of diseases are the major factors driving the
safety syringes market in North America. The market in Asia Pacific is
projected to expand at the highest CAGR in the next few years due to
increase in population, rise in prevalence of diabetes, and surge in
awareness about sharp injuries.
The global safety syringes market is
highly competitive and fragmented due to presence of major companies.
Key players operating in the global safety syringes market include
Becton, Dickinson and Company, Boston Scientific Corporation, B. Braun
Melsungen AG, NIPRO Medical Corporation, Baxter Healthcare Corporation,
Retractable Technologies, Inc., Smiths Medical, Medtronic plc, JMI
Syringes & Medical Devices Limited, and Terumo Medical Corporation.
No comments:
Post a Comment